comparemela.com
  1. Home
  2. Live Updates
  3. GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression : comparemela.com

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

18.01.2024 - DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) - GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced that it recently ... Seite 1

Related Keywords

Theis Terwey ,Gh Research , ,Gh Research Chart ,H Research Kurs ,H Research Aktie ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.